Live feed
Filing
SC 13G/A
SC 13G/A0001387131-23-002065·Atlas Venture Fund XI, L.P.
Schedule 13G ownership disclosure
Day One Biopharmaceuticals Inc
Security class unavailable · CUSIP: 23954D109
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,008,534
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-23-002065
- Form type
- SC 13G/A
- Filer
- Atlas Venture Fund XI, L.P.
- CIK
- CIK 1708269
- Filed
- Feb 14, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership